Kentucky program
Fairer prices for anticancer medicines taken at home
Kentucky law limits unequal cost sharing for certain anticancer medicines.
What it is
Kentucky law limits unequal cost sharing for certain anticancer medicines.
A drug taken at home can otherwise cost more than treatment given through an IV. On an insured Kentucky plan the pill cannot be priced worse than the drip, or the plan caps it at $100 per 30-day supply. A plan where the employer pays its own claims is outside the rule; HR can say which yours is.
Eligibility rules
- A Kentucky health benefit plan that covers both intravenous and patient-administered anticancer medication.
- You must live in Kentucky.
- A high-deductible plan paired with a health savings account applies the alternative route only after the deductible is met.
What you get
- Cost-sharing protection for eligible patient-administered anticancer medicines.
Amounts and limits
- Alternative compliance ceiling on cost sharing per fill: $100.
- Supply period the ceiling applies to: 30 days.
If you decide to apply
- Ask the plan’s pharmacy desk how it applies Kentucky’s anticancer-drug law to the prescribed medicine.
- Have the prescription and quoted cost ready; the clinic pharmacist can help identify the drug.
Oral chemotherapy parity: 800-595-6053 · Official page ↗
If you decide to apply
- The decision comes from the plan.
Good to know
The $100 option is one way to comply. It is not a universal price cap for every prescription.
Other details
- The plan must cover both intravenous and patient-administered anticancer medication. On a high-deductible health savings account plan, the alternative compliance route waits until the deductible is met.
Official sources
“Could this law reduce our prescription costs, what are its limits, and could you help us decide whether to request a pricing review?”
Why I’m asking: I want to understand whether the quoted medicine price follows our plan’s obligations.
More background and detailed requirements
Additional program information and published rules
Who does what
The three parts, side by side. The agency decides; nobody on this page does.
You
Name the law when the price is quoted and keep the reply.
Your social worker
The clinic pharmacist can confirm the drug is an anticancer medication within the law.
The care team
Records and letters when the application asks for them.
- Who decides
- The plan, with the Department of Insurance behind it.
- Ask the billing office
- “This is a patient-administered anticancer medication. How does this plan meet Kentucky's parity law on its cost sharing?”
How to apply
First step: When the pharmacy quotes the price, ask the plan in writing how it meets Kentucky's parity law.
- When the price of a home chemotherapy drug is quoted, ask the plan how it complies with Kentucky's parity law.
- If the plan does not move, complain to the Department of Insurance.
Official application / program page ↗
Where it starts: Name the law to the plan's pharmacy benefit desk when the price jumps, and complain to the Department of Insurance on 800-595-6053 if it does not move.
What to gather
- The pharmacy's quoted price
- The plan's drug list entry for the medicine
- The plan booklet
How long: The plan should answer in days; a complaint to the Department of Insurance follows.
What a yes looks like
A revised price at the pharmacy counter.
What a no looks like, and the next move
Ask whether the plan is insured or self-funded, and complain to the Department of Insurance if it is insured.
Watch out
- The $100 figure is one way a plan can comply, not a promise for every fill.
- On a high-deductible plan with a savings account, that route waits until the deductible is met.
The numbers and the rules
The arcane layer, kept on purpose. Checked September 11, 2026.
What it is worth
Pills priced like the drip. One route to compliance is cost sharing of no more than $100 for each 30-day supply.
- $100 — Alternative compliance ceiling on cost sharing per fill
- $30 — Supply period the ceiling applies to
Legal protection: Cost sharing for patient-administered chemotherapy cannot be worse than for the intravenous form
What it costs the family: Nothing to invoke.
The eligibility facts, as published
- Plan type
- a Kentucky health benefit plan that covers both intravenous and patient-administered anticancer medication
- Residency
- Kentucky
- Exception
- a high-deductible plan paired with a health savings account applies the alternative route only after the deductible is met
The trap: The $100 figure is one way a plan can comply, not a promise that every fill costs $100 or less. And on a high-deductible plan paired with a savings account, that route does not start until the deductible is met.
Where I read this
- KRS 304.17A-172 — Patient-administered anticancer medication parity — Kentucky Legislature, read September 10, 2026
- KRS 304.17A-005 — Definitions for subtitle — Kentucky Legislature, read September 10, 2026
- Kentucky Department of Insurance — Consumer resources — Kentucky Department of Insurance, read September 10, 2026
